The emerging role of gemcitabine in lung cancer

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

ESMO open·2026

Lung cancer research and treatment: global perspectives and strategic calls to action.

Annals of oncology : official journal of the European Society for Medical Oncology·2024

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC).

Annals of oncology : official journal of the European Society for Medical Oncology·2009

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.

Annals of oncology : official journal of the European Society for Medical Oncology·2008

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2007

The role of fumarate and itaconate in tumor microenvironment.

Seminars in oncology·2026

Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons.

Seminars in oncology·2026

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Seminars in oncology·2026

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Seminars in oncology·2026

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Seminars in oncology·2026

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

Seminars in oncology·2026

SKYSCRAPER-05: A Phase 2 Study of Perioperative Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Patients With Previously Untreated, Locally Advanced, Resectable, Stage II‒IIIB NSCLC.

JTO clinical and research reports·2026

A Novel Preclinical Mouse Model of Voluntary Active Stretching Suppresses Mammary Tumor Progression.

Medicine and science in sports and exercise·2026

[A Case of Pembrolizumab-Associated Fulminant Type One Diabetes Mellitus during Neoadjuvant Chemotherapy for Early-Stage Breast Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

[A Case of Giant Exophytic Gastric GIST Presenting with the Torricelli-Bernoulli Sign during Regorafenib Treatment].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

[Optimal Duration of Preventive Minocycline Administration for Skin-Related Adverse Events Induced by Anti-EGFR Antibodies in Metastatic Colorectal Cance].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

[Perioperative Immunotherapy as a Strategy to Overcome Hepatocellular Carcinoma].

Gan to kagaku ryoho. Cancer & chemotherapy·2026

Related Experiment Videos

The emerging role of gemcitabine in lung cancer

Related Concept Videos

Global advances and future directions in lung cancer care: expert consensus and strategic priorities.

Lung cancer research and treatment: global perspectives and strategic calls to action.

Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancer.

ErbB-3 expression is associated with E-cadherin and their coexpression restores response to gefitinib in non-small-cell lung cancer (NSCLC).

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines.

The impact of induction chemotherapy on the outcome of second-line therapy with pemetrexed or docetaxel in patients with advanced non-small-cell lung cancer.

The role of fumarate and itaconate in tumor microenvironment.

Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons.

Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma.

Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework.

Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation.

Atezolizumab, lurbinectedin, tarlatamab, and FOLFIRNOX in a patient with metastatic small cell carcinoma of the anal canal: A case report and review of the literature.

SKYSCRAPER-05: A Phase 2 Study of Perioperative Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Patients With Previously Untreated, Locally Advanced, Resectable, Stage II‒IIIB NSCLC.

A Novel Preclinical Mouse Model of Voluntary Active Stretching Suppresses Mammary Tumor Progression.

[A Case of Pembrolizumab-Associated Fulminant Type One Diabetes Mellitus during Neoadjuvant Chemotherapy for Early-Stage Breast Cancer].

[A Case of Giant Exophytic Gastric GIST Presenting with the Torricelli-Bernoulli Sign during Regorafenib Treatment].

[Optimal Duration of Preventive Minocycline Administration for Skin-Related Adverse Events Induced by Anti-EGFR Antibodies in Metastatic Colorectal Cance].

[Perioperative Immunotherapy as a Strategy to Overcome Hepatocellular Carcinoma].

Related Experiment Videos

The emerging role of gemcitabine in lung cancer

Related Concept Videos

Related Articles